Erythromelalgia is a difficult diagnosis to make and often is a difficult disease for the patient to endure. Special care should be taken by the clinician to search for an underlying disorder when this diagnosis is made and during follow-up. Treatment is directed at the underlying cause, if discernible, and at the symptomatic relief of the patient. Prognosis is mixed; approximately the same number of individuals will improve, remain stable, or worsen, even with referral to a large tertiary care setting with multiple resources.1
Article
Erythromelalgia Misdiagnosed as Cellulitis
Cutis. 2005 January;75(1):37-40
Author and Disclosure Information
Drs. Eaton and Murphy report no conflict of interest. The authors report off-label use of aspirin, gabapentin, heparin, lidocaine patches, misoprostol, serotonin reuptake inhibitors, ticlopidine, topical capsaicin, tricyclic antidepressants, and warfarin for the treatment of erythromelalgia. Dr. Eaton is a Naval Flight Surgeon at Naval Air Facility, Washington, DC. Dr. Murphy is a dermatologist resident, National Naval Medical Center, Bethesda, Maryland.
LT Mark Eaton, MC, USNR; LCDR Sean Murphy, MC, USNR
